Live attenuated measles virus vaccine induces apoptosis and promotes tumor regression in lung cancer

Oncology Reports

Volumn 29, Issue 1, 2013, Pages 199-204

  Zhao, Danhua ^a   Chen, Ping ^b   Yang, Huiqiang ^b   Wu, Yonglin ^b   Zeng, Xianwu ^b   Zhao, Yu ^b   Wen, Yanjun ^c   Zhao, Xia ^a   Liu, Xiaolin ^c   Wei, Yuquan ^a   Li, Yuhua ^a  

^a NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

^b Chengdu Institute of Biological Products   (China)

^c Beijing Tiantan Biological Products Co Ltd   (China)

Author keywords

Apoptosis; Live attenuated measles virus vaccine; Oncolytic therapy

Indexed keywords

MEASLES VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; CHINA; CONTROLLED STUDY; EMBRYO; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LEWIS CARCINOMA; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR NECROSIS;

ANIMALS; APOPTOSIS; CARCINOMA, LEWIS LUNG; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MEASLES; MEASLES VACCINE; MEASLES VIRUS; MICE; MICE, INBRED C57BL; MICE, NUDE; ONCOLYTIC VIROTHERAPY; TUMOR CELLS, CULTURED; VACCINES, ATTENUATED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84872867835     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2109     Document Type: Article

References (32)

1. Minna JD, Roth JA and Gazdar AF: Focus on lung cancer. Cancer Cell 1: 49-52, 2002.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 57: 43-66, 2007.
3. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J and Johnson DH; Eastern Cooperative Oncology Group: Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346: 92-98, 2002.
4. Khuri FR, Herbst RS and Fossella FV: Emerging therapies in non-small-cell lung cancer. Ann Oncol 12: 739-744, 2001.
5. Soria JC, Jang SJ, Khuri FR, Hassan K, Liu D, Hong WK and Mao L: Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res 60: 4000-4004, 2000.
6. Vora SA, Daly BD, Blaszkowsky L, McGrath JJ, Bankoff M, Supran S and Dipetrillo TA: High dose radiation therapy and chemotherapy as induction treatment for stage III nonsmall cell lung carcinoma. Cancer 89: 1946-1952, 2000.
7. Peng KW, Facteau S, Wegman T, O'Kane D and Russell SJ: Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides. Nat Med 8: 527-531, 2002.
8. Zhong H, Han B, Tourkova IL, Lokshin A, Rosenbloom A, Shurin MR and Shurin GV: Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth. Clin Cancer Res 13: 5455-5462, 2007.
9. Erlenhoefer C, Wurzer WJ, Löffler S, Schneider-Schaulies S, ter Meulen V and Schneider-Schaulies J: CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition. J Virol 75: 4499-4505, 2001.
10. Tatsuo H, Ono N, Tanaka K and Yanagi Y: SLAM (CDw150) is a cellular receptor for measles virus. Nature 406: 893-897, 2000.
11. Hsu EC, Iorio C, Sarangi F, Khine AA and Richardson CD: CDw150 (SLAM) is a receptor for a lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus. Virology 279: 9-21, 2001.
12. Dörig RE, Marcil A, Chopra A and Richardson CD: The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75: 295-305, 1993.
13. Naniche D, Varior-Krishnan G, Cervoni F, Wild TF, Rossi B, Rabourdin-Combe C and Gerlier D: Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 67: 6025-6032, 1993.
14. Bjørge L, Hakulinen J, Wahlström T, Matre R and Meri S: Complement-regulatory proteins in ovarian malignancies. Int J Cancer 70: 14-25, 1997.
15. Grote D, Russell SJ, Cornu TI, Cattaneo R, Vile R, Poland GA and Fielding AK: Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. Blood 97: 3746-3754, 2001.
16. Grote D, Cattaneo R and Fielding AK: Neutrophils contribute to the measles virus-induced antitumor effect: enhancement by granulocyte macrophage colony-stimulating factor expression. Cancer Res 63: 6463-6468, 2003.
17. Peng KW, Ahmann GJ, Pham L, Greipp PR, Cattaneo R and Russell SJ: Systemic therapy of myeloma xenografts by an attenuated measles virus. Blood 98: 2002-2007, 2001.
18. Dingli D, Peng KW, Harvey ME, Greipp PR, O'Connor MK, Cattaneo R, Morris JC and Russell SJ: Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. Blood 103: 1641-1646, 2004.
19. Phuong LK, Allen C, Peng KW, Giannini C, Greiner S, TenEyck CJ, Mishra PK, Macura SI, Russell SJ and Galanis EC: Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme. Cancer Res 63: 2462-2469, 2003.
20. Peng KW, TenEyck CJ, Galanis E, Kalli KR, Hartmann LC and Russell SJ: Intraperitoneal therapy of ovarian cancer using an engineered measles virus. Cancer Res 62: 4656-4662, 2002.
21. Pumphrey CY, Theus AM, Li S, Parrish RS and Sanderson RD: Neoglycans, carbodiimide-modified glycosaminoglycans: a new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis. Cancer Res 62: 3722-3728, 2002.
22. Wei YQ, Zhao X, Kariya Y, Fukata H, Teshigawara K and Uchida A: Induction of apoptosis by quercetin: involvement of heat shock protein. Cancer Res 54: 4952-4957, 1994.
23. Gorczyca W, Gong J, Ardelt B, Traganos F and Darzynkiewicz Z: The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res 53: 3186-3192, 1993.
24. Barry MA, Reynolds JE and Eastman A: Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification. Cancer Res 53: 2349-2357, 1993.
25. Sauter BV, Martinet O, Zhang WJ, Mandeli J and Woo SL: Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases. Proc Natl Acad Sci USA 97: 4802-4807, 2000.
26. Wei YQ, Hang ZB and Liu KF: In situ observation of infl ammatory cell-tumor cell interaction in human seminomas (germinomas): light, electron microscopic, and immunohistochemical study. Hum Pathol 23: 421-428, 1992.
27. Li G, Tian L, Hou JM, Ding ZY, He QM, Feng P, Wen YJ, Xiao F, Yao B, Zhang R, Peng F, Jiang Y, Luo F, Zhao X, Zhang L, Zhou Q and Wei YQ: Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with cisplatin in solid tumors. Clin Cancer Res 11: 4217-4224, 2005.
28. Xiao F, Wei Y, Yang L, Zhao X, Tian L, Ding Z, Yuan S, Lou Y, Liu F, Wen Y, Li J, Deng H, Kang B, Mao Y, Lei S, He Q, Su J, Lu Y, Niu T, Hou J and Huang MJ: A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin. Gene Ther 9: 1207-1213, 2002.
29. Peto R and Peto J: Asymptotically efficient rank invariant test procedures. J R Stat Soc Ser A 135: 185-207, 1972.
30. Malaguarnera L: Implications of apoptosis regulators in tumorigenesis. Cancer Metastasis Rev 23: 367-387, 2004.
31. Liu TC and Kim D: Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions. Cancer Res 67: 429-432, 2007.
32. Parato KA, Senger D, Forsyth PA and Bell JC: Recent progress in the battle between oncolytic viruses and tumours. Nat Rev Cancer 5: 965-976, 2005.